PVP Biotechnology Companies Show Strong Momentum: GI Dynamics, Cerulean Pharma, Selecta Biosciences

Posted on by

Three PVP biotechnology companies have recently made headlines for their strong business and research momentum.

First, despite a very difficult initial public offering market, Polaris-backed GI Dynamics recently raised approximately $85 million (USD), completing the largest IPO so far this year on the Australian market. The company began trading on the Australian Securities
Exchange last week. The strong support GI Dynamics received from investors is due to the commercial potential of the company’s lead product, EndoBarrier, as well as to the company’s consistent execution across its research, development, and commercialization plans.

Cerulean Pharma and Selecta Biosciences were also included in the FierceBiotech
2011 Fierce 15. This year’s Fierce 15 includes private life sciences companies “out to
do something truly exceptional”…with…”pioneering technology and innovative business models.”

Continue reading →

Eleven Polaris-backed Businesses Make Inc. Magazine 500|5000 List

Posted on by

When Inc. Magazine published its 2011 list of the top 5,000 fastest growing companies in the United States, we noted that eleven Polaris Venture Partners-backed companies had been recognized. To put this list in some perspective, Inc. Magazine estimates that there are over 7 million privately held companies in the U.S.

The list acknowledges U.S. companies that experienced significant growth over the past three years. This consistent growth signals the market demand for the innovative
products and services that these companies provide, as well as their strength
of position in each sector. Continue reading →